Results 221 to 230 of about 10,365,683 (253)
Some of the next articles are maybe not open access.

Is docosahexaenoic acid supplementation effective in non‐proliferative diabetic retinopathy?

Acta Ophthalmologica, 2022
AbstractWe evaluated the effect of 2‐year supplementation with a highly concentrated docosahexaenoic acid (DHA) product with antioxidant activity on nonproliferative diabetic retinopathy (NPDR). A prospective, randomized, double‐blind, placebo‐controlled study was performed. A total of 170 patients with diabetes were randomly assigned to the DHA group (
openaire   +1 more source

Detection and Classification of Non-Proliferative Diabetic Retinopathy Lesions

2019
The World Health Organization (WHO) predicted that in the year 2012 about 347 million people worldwide would be suffering from diabetes, and more than 80% deaths occur due to diabetes in different countries. WHO projects that diabetes will be the seventh major cause of death in 2030. Diabetic retinopathy begins with a leakage of blood or fluid from the
Ramesh R. Manza   +3 more
openaire   +1 more source

Detection and Classfication of Non-proliferative Diabetic Retinopathy Using Retinal Images

2019
Diabetic retinopathy is one of the general eye disease observed in diabetic patients and which is the most important reason of vision loss. Cataracts and glaucoma are some other eye diseases found in diabetic patients due to complication in diabetes.
D. B. Mule   +2 more
openaire   +1 more source

Detection of Non-proliferative Diabetic Retinopathy using GUI

2022 2nd International Conference on Innovative Practices in Technology and Management (ICIPTM), 2022
Yogesh Kumar, Nikhil Poonia, Prince Jain
openaire   +1 more source

Non-proliferative Diabetic Retinopathy

2007
Amod Gupta   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy